The effect of raloxifene on the uterine weight response in immature mice exposed to 17β-estradiol, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane, and methoxychlor

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 5, 2000, Pages 1099-1102

  Al Jamal, John H ^a   Dubin, Norman H ^a  

^a UNION MEMORIAL HOSPITAL   (United States)

Author keywords

1,1,1 Trichloro 2,2 bis(p chlorophenyl)ethane (DDT); 17 estradiol; Immature mice; Methoxychlor; Raloxifene; Tamoxifen; Xenoestrogens

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; ESTRADIOL; ESTROGEN RECEPTOR; METHOXYCHLOR; RALOXIFENE; SESAME SEED OIL; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; FEMALE; IMMATURITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERUS WEIGHT;

EID: 0034129697     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.105407     Document Type: Article

References (10)

1. 1. Beauregard L. Women's health and the environment. In: Haseltine FP, Jacobson BG, editors. Women's health research. Washington: American Psychiatric Press; 1997. p. 189-217.
2. 2. Cummings AM, Lashey J. Effect of methoxychlor on ovarian steroidogenesis: role in early pregnancy loss. Reprod Toxicol 1993;7:17-23.
3. 3. Cummings AM, Metcalf JL. Methoxychlor regulates rat uterine estrogen-induced protein. Toxicol Appl Pharmacol 1995;130: 154-60.
4. 4. Eroschenko VP. Ultrastructure of vagina and uterus in young mice after methoxychlor exposure. Reprod Toxicol 1991;5:427-35.
5. 5. Baker VL, Jaffe RB. Clinical uses of antiestrogens. Obstet Gynecol Surv 1995;51:45-59.
6. 6. Abramowicz M. Raloxifene for postmenopausal osteoporosis. Med Lett 1998;40:29-31, 1022.
7. 7. Draper MW, Flowers DE, Neild JA, Huster WJ, Zerbe RL. Antiestrogenic properties of raloxifene. Pharmacology 1995;50:209-17.
8. 8. Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene [published erratum appears in Science 1997;275:1249]. Science 1996;273:1222-4.
9. 9. Branham WS, Zehr DR, Sheehan DM. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med 1993;203:297-302.
10. 10. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Wlliams DC, et al. Raloxifene (LY139481HCL.) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 1994;93:63-9.